Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian ...

Enhertu plus Perjeta demonstrated improvement in progression-free survival versus standard treatment in HER2-positive ...

Don’t aspire to make a living. Let’s aspire to make a difference in the Mandarin/Cantonese-speaking community.” ...

I share my unique aggressive treatment journey over 11 years, highlighting a common hope for more time and better treatments.

Pausing treatment during vaccination did not improve immunity in patients with chronic lymphocytic leukemia and should not be ...

Carly Stafford Dixon, a rare cancer survivor, highlights the need for AYA cancer awareness to improve support, visibility and access to vital resources.

In some patients with advanced triple-negative breast cancer, Trodelvy plus Keytruda was associated with an improvement in disease progression.

After nearly 30 years with cancer — community, research and education have helped us find hope, strength and purpose in the ...

Bavencio improved survival in patients with bladder cancer, irrespective of diabetes status, according to an analysis of the ...

Optimal dosing of Jakafi was associated with improved efficacy and manageable safety in patients with myelofibrosis, ...

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

The journey that led to the creation of the Extraordinary Healer Award for Oncology Nursing began with a simple, yet profound ...